TTC30A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.895400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.423000E-01
Normal-vs-Stage2
8.649000E-01
Normal-vs-Stage3
5.027200E-01
Normal-vs-Stage4
4.642000E-01
Stage1-vs-Stage2
3.574000E-01
Stage1-vs-Stage3
1.732320E-02
Stage1-vs-Stage4
6.591400E-01
Stage2-vs-Stage3
3.491000E-01
Stage2-vs-Stage4
4.298600E-01
Stage3-vs-Stage4
2.550400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.157800E-01
Normal-vs-AfricanAmerican
5.784600E-01
Normal-vs-Asian
7.018200E-01
Caucasian-vs-AfricanAmerican
6.676400E-01
Caucasian-vs-Asian
6.045400E-01
AfricanAmerican-vs-Asian
8.561800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.279600E-01
Normal-vs-Female
6.437000E-01
Male-vs-Female
1.151770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.284000E-01
Normal-vs-Age(41-60Yrs)
5.350400E-01
Normal-vs-Age(61-80Yrs)
9.852800E-01
Normal-vs-Age(81-100Yrs)
9.384600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.622400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.288800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.659820E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.808490E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.714200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.664800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.734800E-01
Normal-vs-Daily Drinker
7.451400E-01
Normal-vs-Weekly Drinker
6.000200E-01
Normal-vs-Occasional Drinker
4.807400E-01
Normal-vs-Social Drinker
5.480200E-01
Non Drinker-vs-Daily Drinker
6.565200E-01
Non Drinker-vs-Weekly Drinker
4.830800E-01
Non Drinker-vs-Occasional Drinker
6.990100E-02
Non Drinker-vs-Social Drinker
1.368970E-01
Daily Drinker-vs-Weekly Drinker
8.092600E-01
Daily Drinker-vs-Occasional Drinker
4.998300E-02
Daily Drinker-vs-Social Drinker
6.741900E-02
Weekly Drinker-vs-Occasional Drinker
3.613600E-02
Weekly Drinker-vs-Social Drinker
6.751800E-02
Occasional Drinker-vs-Social Drinker
6.496600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.139450E-01
Normal-vs-Grade 2
9.584400E-02
Normal-vs-Grade 3
3.571800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.155000E-01
Grade 1-vs-Grade 3
9.095400E-01
Grade 1-vs-Grade 4
1.139450E-01
Grade 2-vs-Grade 3
4.346600E-01
Grade 2-vs-Grade 4
9.584400E-02
Grade 3-vs-Grade 4
3.571800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.448600E-01
Normal-vs-NonDiabetic
7.046800E-01
Diabetic-vs-NonDiabetic
1.263270E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.025000E-01
Normal-vs-NoPancreatitis
8.132000E-01
Pancreatitis-vs-NoPancreatitis
3.951000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.166400E-01
Normal-vs-N1
8.144400E-01
N0-vs-N1
9.707600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.555200E-01
Normal-vs-TP53-NonMutant
5.601200E-01
TP53-Mutant-vs-TP53-NonMutant
5.731400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
